Franklin Resources
OCUL icon

Franklin Resources’s Ocular Therapeutix OCUL Stock Holding History

Franklin Resources’s Portfolio OCUL Stock Details OCUL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-1,170,163
Closed -$10.9M – 3221
2025
Q2 		$10.9M Sell
1,170,163
-96
-0% -$751 ﹤0.01% 1105
2025
Q1 		$8.58M Buy
1,170,259
+3
+0% +$23 ﹤0.01% 1151
2024
Q4 		$9.99M Hold
1,170,256
– – ﹤0.01% 1125
2024
Q3 		$12.2M Buy
1,170,256
+93
+0% +$767 ﹤0.01% 1050
2024
Q2 		$8M Sell
1,170,163
-998,150
-46% -$6.16M ﹤0.01% 1150
2024
Q1 		$19.7M Sell
2,168,313
-2,331,846
-52% -$16.5M 0.01% 873
2023
Q4 		$20.1M Buy
+4,500,159
New +$13.3M 0.01% 753

Other funds holding OCUL

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
VA
VR Adviser New York $2.68B AUM 422.73% 1-Year Est. Return
SR
Summer Road West Palm Beach, Florida $142M AUM 43.61% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $3.5B AUM 1,165.83% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

Franklin Resources's OCUL Position: Q3 2025 in Review

Franklin Resources sold out of Ocular Therapeutix (OCUL) in Q3 2025, closing a stake of 1,170,163 shares — an estimated $10.9M sold.

Franklin Resources first reported a position in OCUL in Q4 2023 and held it in 7 quarters. The position peaked at $20.1M in Q4 2023. 216 funds tracked by Wall St. Rank hold OCUL as of Q3 2025.

  • Franklin Resources reported no remaining Ocular Therapeutix position as of Q3 2025 after selling out during the quarter.
  • Franklin Resources sold 1,170,163 Ocular Therapeutix shares in Q3 2025, an estimated $10.9M.
  • Franklin Resources first reported a position in Ocular Therapeutix in Q4 2023 and held it in 7 quarters.
  • Franklin Resources's Ocular Therapeutix position peaked at $20.1M in Q4 2023.
  • 216 funds tracked by Wall St. Rank held Ocular Therapeutix as of Q3 2025.

Based on Franklin Resources's 13F filing for Q3 2025, filed 13 Nov 2025.